Endosense names new CFO | Personnel Moves

Endosense names new CFO
Endosense named Nicolas Marsault as the company’s new CFO. He has replaced Endosense’s previous CFO Andrea Buscaglia.

The Cather ablation technology maker won CE Mark approval in the European Union for its 3rd-generation TactiCath Quartz in June. Marsault will focus on expanding the commercial presence of the device and planning to launch the product in the U.S.

“We welcome Nicolas to our team at a pivotal time of growth for the company,” Endosense president, CEO and chairman Jan Keltjens said in prepared remarks. “With his strong background in both finance and science, we expect him to play a critical role in the expansion of our business worldwide.”

Pior to Endosense, Marsault worked at Merck Serono, Saint Gobain, and Péchiney, which was acquired by Alcan in 2003.

Guertin was the former president & CEO of Varian Medical (NYSE:VAR) , prior to which, he was president of Varian’s Oncology Systems business. Guertin is also a member of the board of directors of Varian Medical Systems and Teradyne, as well as on the board of the Radiation Oncology Institute. Read more

Dormer joined the EOS Board earlier this year, prior to which, he was the chairman of Johnson & Johnson (NYSE:JNJ) medical devices & diagnostics divisionand president of DePuy. He is also on the executive committee of AdvaMed.Read more